UNSPSC 51282614: Cefpirome sulfate

This classification denotes a cephalosporin antibiotic with the molecular formula C22H22N6O5S2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BA5ALU2ZT9, chemically known as 5h-1-pyrindinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-6,7-dihydro-, hydroxide, inner salt, (6r-(6alpha,7beta(z)))-, sulfate (1:1) but more generally known as cefpirome sulfate, which bears US NIH Compound Identifier 9570928.

UNSPSC 51282614 Cefpirome sulfate is a Commodity code that nominally designates a specific injectable antibiotic, but the recent state and local procurement record shows little activity directly aligned with this narrow pharmaceutical product. The code does not appear in active state or local solicitations for cefpirome itself; instead, the tagged opportunities reflect broader pharmaceutical and medical supply procurement—including antibiotic tablets, overdose-reversal agents, and drug-deactivation systems—through warehouse and piggyback contracts managed by state health departments and county public health authorities.

State and local buyers under this code are primarily state health departments and county health authorities. The Illinois Department of Public Health awarded a $2.999 million piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and Seminole County, Florida issued an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually. Activity is scattered across Illinois and Florida, with no concentration evident from the limited recent record. The Illinois contract involved an Invitation for Bid process with a 12-month initial term and renewal options through year 3; the Seminole County IFB specified a two-year initial term with a one-year renewal option and quarterly deliveries. Neither opportunity explicitly required set-aside designations. The mismatch between the code's specificity (cefpirome sulfate) and the actual procurement scope (mixed antibiotic and public-health supplies) suggests this code may be misapplied in state and local tagging systems or that cefpirome solicitations occur infrequently under state and local procurement channels.